The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
There is no floor Roger. This could easily go into the low single digits, at which time it becomes a buy again.
Does anyone remember the company statement that “positive news flow” over the next months would provide a liquidity for the stock to make this financing deal the best available?
That worked out well didn’t it?
I make of that that RF is going to get an absolutely huge tranche of shares at a low strike price in order for GDR to limps long for another month!
This is why stop losses exist. I admit I never saw this coming, but you have to safeguard yourself against these kinds of eventualities. There are no buyers, RF is dumping, there is no floor here.
Anyone still holding a position has only themselves to blame. Although of course it is easier to blame Dudd, or Riverfort, or NICE or whomever.
Afraid I’ve been stopped out.
I’ll keep monitoring the stock and might get back in. It will probably rebound now it has hit my stop loss, sigh.
Annoying.
I’m in with a small position Stephen. Significantly less than my gains have been historically so I won’t be out of pocket even if GDR goes bust. And I think we are some way from that, if it ever happens.
We seem to have bottomed and there is a good potential upside with the stroke product getting considered by NICE in the next few months.
The broker fees are insignificant relative to the size of my trades (how much do you pay for each trade then??) but the large spread certainly hits your profit margins if you trade frequently. Luckily this a share with big swings.
I’m never short, so I’m looking for a sustained rise into which I can average up. I still see that as a possibility with the NICE consideration. But we’ll see.
Obviously I’ve got a stop loss in case the bottom falls out. I don’t pump the stock when I’m in or bash it when I’m out. I just say what I think because I’m convinced this board has no real impact on the stock’s performance.
If it were going to come wouldn’t it have already?
I know.
This company may well be a sad example of yet another British company with world beating ideas and products getting beaten to the punch by the superior sales and marketing and general business nous of foreign competition with inferior products.
How many inventions and ideas do we come up that others make the big bucks out of?
Get your finger out Genedrive. Start selling , start getting approvals to sell, or someone else will eat your lunch..
I was thinking about your disturbed night Sprout and it reminded me of the wise old Wall Street adage:
“Sell down to the sleeping point.”
Understandable
I bet you find it a relief. There are other things you can do with the money it’s no longer dead, and you can always buy in again (almost certainly much much lower) if things show any sign of picking up here.
You’ve been very sensible and I applaud your courage. Well done and good luck.
Still not too late to get out!
In just over an hour and half it will be.
You’ll look back on this time, if you don’t sell, with great regret.
Why?
They could talk about the fact that they aren’t able to file accounts?
If you are still holding (maybe you already sold I would hope so?) I would get out well before any communication from the company. Take the loss and live to fight another day with whatever you can salvage
Anyone who advises otherwise is selling a dream that isn’t going to come true.
This is pretty nasty.
You guys are invested in the stock. We get it.
But attacking someone in such a personal manner, bringing their ex wife into it. Just because he disagrees with your investment proposition…
Distinctly unimpressive.
if you are right the stock will shoot up and you will make the big bucks. That ought to be enough for you.
This kind of abuse merely suggests a deep lack of confidence in your own investment.
And I say this as a (fairly large) stockholder myself. (For now).
That’s a very good question.
I’m reminded of the Cloudtag forum as it approached its denouement.
I see that I have had a post removed. It was more than inoffensive. But it questioned the party line on here. That’s a huge red flag for me.
All I will say is watch out. There appears to be a three line whip enforced on posters.
Why? Cui bono?
No doubt this post will be expunged also…
No idea what is going on and I don’t trust it.
I’m in of course, and hope we get a nice little spike upwards from here, but I can’t help feeling that RF will choke off any rally eventually.
(I suppose I shouldn’t admit that since I am in, I should be all ra ra ra. But I think there is a duty to be honest. This isn’t just about making money, you have to have some integrity).
Let’s hope there is some good news ahead!
Yeah well NICE has to work out if the NHS can afford a drug, not just its efficacy and safety.
The FDA just worries if it works and is safe.
It’s an intensely hostile environment for a tiny company like GDR.
It’s not going to shoot up very fast indeed because RF will sell into any spike and kill it stone dead. Like they did the DEVOTE announcement.
Until the RF overhang is cleared the share price is going nowhere. Except further down maybe.
If the share price goes below 16 that will be a material breach of the deal as I understand it. If either party wants to enforce the breach.
But surely RF hold the whip hand here? GDR needs the monthly drawdowns to fund the business and pay Budd’s salary. RF on the other want their money back (not unreasonably actually) and will keep selling shares until they get it. Surely? Why would they stop just because there are still no sales and the share price keeps going down?
Who knows what GDR might have to promise to keep the money flowing? They’ve really only got two levers to pull. Further share dilution and/or warrants.
RF hold ALL the power here in any negotiations that might ensue if the share price goes below 16 and stays down. And from what we know they drive a hard bargain.
Unless there are other funding sources available for a company with a rapacious appetite for cash and no sales?
We’ll see bighammer. You may be right, not saying you aren’t.
(Kudos is spelt with a K though. ;-). )
My understanding is that the FDA is incredibly bureaucratic and lacking in flexibility and insistent on only US sourced data.
It’s going to be hard for a small foreign company like Genedrive to jump through the hoops without a lot of financing.
A US partner would be a different story of course. But there is no concrete sign of one that I am aware.